2026-09-19T23:11:06Zhttps://dspace.mit.edu/server/oai/requestoai:dspace.mit.edu:1721.1/421522022-01-13T07:54:33Zcom_1721.1_7582com_1721.1_7581col_1721.1_131023
Caroline Anne Ross.
Wiryaatmadja, Edwina
Massachusetts Institute of Technology. Dept. of Materials Science and Engineering.
Massachusetts Institute of Technology. Department of Materials Science and Engineering
2008-09-03T14:44:21Z
2008-09-03T14:44:21Z
2007
2007
http://hdl.handle.net/1721.1/42152
228417099
Thesis (M. Eng.)--Massachusetts Institute of Technology, Dept. of Materials Science and Engineering, 2007.
Includes bibliographical references (p. 83-88).
Under alternating magnetic field, superparamagnetic iron oxide nanoparticles can be used to generate heat for the treatment of cancer. With suitable coating, these nanoparticles are biocompatible, stable in solution, and absorbed by tumor cells in good contrast. The mechanism of heating is mainly due to Neel relaxation process and a quantity called specific loss power (SLP) / specific absorption rate (SAR) is used to describe the heating effect. Past clinical studies have shown minimum side effects and proven the success of the new thermotherapy as a treatment modality in conjunction with chemo- or radiotherapy. Studies are in progress to improve the nanoparticles' heating power to enable treatment of small tumors and metastases, thermoablation as a monotherapy, and to achieve tumor-specific thermotherapy with the aid of tumor-finding molecules. This paper evaluates the novel technology that is magnetic nanoparticles-based thermotherapy and explores its commercialization potential. It explains the medical need driving the innovation, examines the technology in comparison with existing cancer therapies, identifies the strategic position the technology has in the present state of market for cancer therapies, and explores opportunities and Challenges in the introduction of the new therapy into the U.S. market.
by Edwina Wiryaatmadja.
M.Eng.
88 p.
eng
Massachusetts Institute of Technology
M.I.T. theses are protected by
copyright. They may be viewed from this source for any purpose, but
reproduction or distribution in any format is prohibited without written
permission. See provided URL for inquiries about permission.
http://dspace.mit.edu/handle/1721.1/7582
Materials Science and Engineering.
Evaluation of nanoparticles-based thermotherapy for cancer
Thesis
application/pdf
false
Publication
unknown
unknown
<Publication xmlns="https://www.openaire.eu/cerif-profile/1.1/" id="e792465c-d767-485b-b290-d0f925855cbb">
<Type xmlns="https://www.openaire.eu/cerif-profile/vocab/COAR_Publication_Types">http://purl.org/coar/resource_type/c_1843</Type>
<Language>eng</Language>
<Title>Evaluation of nanoparticles-based thermotherapy for cancer</Title>
<PublishedIn>
<Publication>
</Publication>
</PublishedIn>
<PublicationDate>2007</PublicationDate>
<Authors>
<Author>
<DisplayName>Wiryaatmadja, Edwina</DisplayName>
<Affiliation>
<OrgUnit>
</OrgUnit>
</Affiliation>
</Author>
</Authors>
<Editors>
</Editors>
<Publishers>
<Publisher>
<DisplayName>Massachusetts Institute of Technology</DisplayName>
<OrgUnit />
</Publisher>
</Publishers>
<License>http://dspace.mit.edu/handle/1721.1/7582</License>
<Keyword>Materials Science and Engineering.</Keyword>
<Abstract>Under alternating magnetic field, superparamagnetic iron oxide nanoparticles can be used to generate heat for the treatment of cancer. With suitable coating, these nanoparticles are biocompatible, stable in solution, and absorbed by tumor cells in good contrast. The mechanism of heating is mainly due to Neel relaxation process and a quantity called specific loss power (SLP) / specific absorption rate (SAR) is used to describe the heating effect. Past clinical studies have shown minimum side effects and proven the success of the new thermotherapy as a treatment modality in conjunction with chemo- or radiotherapy. Studies are in progress to improve the nanoparticles' heating power to enable treatment of small tumors and metastases, thermoablation as a monotherapy, and to achieve tumor-specific thermotherapy with the aid of tumor-finding molecules. This paper evaluates the novel technology that is magnetic nanoparticles-based thermotherapy and explores its commercialization potential. It explains the medical need driving the innovation, examines the technology in comparison with existing cancer therapies, identifies the strategic position the technology has in the present state of market for cancer therapies, and explores opportunities and Challenges in the introduction of the new therapy into the U.S. market.</Abstract>
<Access xmlns="http://purl.org/coar/access_right"
>
</Access>
</Publication>